Health Catalyst officer to sell 321 shares

Health Catalyst, Inc. (HCAT) officer Benjamin Albert filed a Form 144 indicating a proposed sale of 321 shares of common stock, to be sold through Morgan Stanley Smith Barney LLC on or about 09/01/2026 under Rule 144.

Rhea-AI Filing Summary

Health Catalyst, Inc. (HCAT) officer Benjamin Albert filed a Form 144 indicating a proposed sale of 321 shares of common stock, to be sold through Morgan Stanley Smith Barney LLC on or about 09/01/2026 under Rule 144. The securities are restricted stock originally acquired as compensation. Over the prior three months, Albert reported Rule 144 sales of restricted stock on 06/01/2026 and 06/10/2026.

Key Figures

Shares proposed to be sold: 321 shares of common stock Shares sold in past 3 months: 336 shares Shares sold in past 3 months: 34,485 shares +2 more

5 metrics

Shares proposed to be sold 321 shares of common stock Planned Rule 144 sale on or about 09/01/2026

Shares sold in past 3 months 336 shares Restricted stock sale on 06/01/2026

Shares sold in past 3 months 34,485 shares Restricted stock sale on 06/10/2026

Amount for 06/01/2026 sale 460.39 Reported amount associated with 336-share sale of restricted stock

Amount for 06/10/2026 sale 58,341.72 Reported amount associated with 34,485-share sale of restricted stock

Key Terms

Rule 144, restricted stock, compensation, Form 144

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock financial

"Common | 09/01/2026 | Restricted Stock | Health Catalyst, Inc."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

compensation financial

"321 | 09/01/2026 | Compensation"

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

What insider transaction did Health Catalyst, Inc. (HCAT) disclose in this Form 144?

The filing states that officer Benjamin Albert intends to sell 321 shares of common stock of Health Catalyst, Inc. under Rule 144, with the planned sale date of 09/01/2026 through Morgan Stanley Smith Barney LLC.

How many Health Catalyst (HCAT) shares are proposed to be sold under this Form 144?

The notice covers a proposed sale of 321 shares of Health Catalyst, Inc. common stock. These are described as restricted stock that were originally acquired as compensation and are to be sold pursuant to Rule 144.

When is the proposed Rule 144 sale for HCAT scheduled?

The proposed Rule 144 sale of Health Catalyst, Inc. common stock by Benjamin Albert is listed with an intended sale date of 09/01/2026. The securities are to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ market.

What type of securities are being sold under Rule 144 for Health Catalyst (HCAT)?

The filing identifies the securities as restricted stock of Health Catalyst, Inc., classified as common stock. The shares were acquired as compensation and are now the subject of a proposed resale under SEC Rule 144.

What prior sales has Benjamin Albert made in Health Catalyst (HCAT) stock in the last 3 months?

The Form 144 lists prior sales of restricted stock by Benjamin Albert of 336 shares on 06/01/2026 and 34,485 shares on 06/10/2026. These transactions are reported as sales during the past three months under Rule 144.

Who is the broker for the proposed Health Catalyst (HCAT) Form 144 sale?

The proposed sale of 321 shares of Health Catalyst, Inc. common stock is to be executed through Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 38th Floor, New York, NY 10004, as disclosed in the Form 144 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 05:49 PM Accepted by SEC EDGAR 09/01/2026 - 05:48 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002086403
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Health Catalyst, Inc.
SEC File Number	001-38993
Address of Issuer	10897 S River Front Pkwy #300 South Jordan UTAH 84095
Phone	8553096800
Name of Person for Whose Account the Securities are To Be Sold	Benjamin Albert
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	321	546.86	75256381	09/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2026	Restricted Stock	Health Catalyst, Inc.			321	09/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Benjamin Albert c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	06/01/2026	336	460.39
Benjamin Albert c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	06/10/2026	34485	58341.72

144: Remarks and Signature

Remarks
Date of Notice	09/01/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Benjamin Albert
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)